Dehaier Medical to Present at 2013 Annual Congress of Chinese Thoracic Society

Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier" or the "Company"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products, today announced that it will present its Morpheus Ox System at the 2013 Annual Congress of Chinese Thoracic Society in Dalian, Shandong Province from September 18-21, 2013.

The Morpheus Ox System is a cost-effective, portable home sleep diagnostic and monitoring solution that enables the diagnosis of sleep disorders using a standard oximeter recording plethysmograph signal. By collecting and recording the physiological data from patients who wear the watch-sized device at home, the advanced automatic sleep scoring software generates an accurate and reliable sleep study diagnosis, including Apnea Hypopnea Index (AHI), sleep/wake time, and Cheyne-Stokes breathing patterns. The new generation Morpheus Ox is a comprehensive platform that manages a cost-effective sleep services operation, including patient electronic medical records, cardiac and sleep diagnostics outcomes and complete workflow management. The web-based automatic scoring and data management facilitates operational efficiency and maximizes growth potential by giving users valuable and timely clinical information to improve patient treatment.

The Annual Congress of Chinese Thoracic Society is one of China's most influential and comprehensive respiratory diseases congresses and an important platform for presenting advanced research results and improving the industry development. The Congress is sponsored by the Chinese Medical Doctor Association and co-hosted by Chinese Thoracic Society.

About Dehaier Medical Systems Ltd.

Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents, nine software copyrights and proprietary technology. More information may be found at http://www.dehaier.com.cn

Forward-looking Statements

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular any implications regarding the Dehaier's attendance of 2013 Annual Congress of Chinese Thoracic Society. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

CONTACT: Dehaier Medical Systems Limited
         Surie Liu
         [phone]
         [e-mail]
         
         Dehaier Medical Systems Limited
         Tina He
         [phone]
         [e-mail]